Cas:94108-97-1 di(trimethylolpropane) tetraacrylate manufacturer & supplier

Chemical Name:di(trimethylolpropane) tetraacrylate

CAS.NO:94108-97-1

Synonyms:MFCD00192118;hyl-1,3-propanediylester;EINECS 302-434-9

Molecular Formula:C₂₄H₃₄O₉

Molecular Weight:466.52100

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:540.4ºC at 760mmHg

Density:1.096g/cm3

Index of Refraction:n20/D 1.479(lit.)

PSA:114.43000

Exact Mass:466.22000

LogP:2.71260

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:NONH for all modes of transpor

Packing Group:

Contact us for information like MFCD00192118 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,EINECS 302-434-9 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,hyl-1,3-propanediylester Use and application,hyl-1,3-propanediylester technical grade,usp/ep/jp grade.

Related News: Refers to the active pharmaceutical ingredients used in the manufacture of original research drugs (patent drugs or innovative drugs). It mainly meets the needs of international original research drug companies and emerging biopharmaceutical companies for innovative drugs at various stages of clinical research, registration approval and commercialization of drugs. Contains advanced intermediates used in the manufacture of this drug substance that need to be regulated by regulatory authorities. di(trimethylolpropane) tetraacrylate manufacturer An analysis of the top 20 global companies by R&D spend for 2018 shows that companies with expensive late-stage pipeline drugs are spending significant proportions of their annual revenue on R&D. di(trimethylolpropane) tetraacrylate supplier An analysis of the top 20 global companies by R&D spend for 2018 shows that companies with expensive late-stage pipeline drugs are spending significant proportions of their annual revenue on R&D. di(trimethylolpropane) tetraacrylate vendor Refers to the active pharmaceutical ingredients used in the manufacture of original research drugs (patent drugs or innovative drugs). It mainly meets the needs of international original research drug companies and emerging biopharmaceutical companies for innovative drugs at various stages of clinical research, registration approval and commercialization of drugs. Contains advanced intermediates used in the manufacture of this drug substance that need to be regulated by regulatory authorities. di(trimethylolpropane) tetraacrylate factory An analysis of the top 20 global companies by R&D spend for 2018 shows that companies with expensive late-stage pipeline drugs are spending significant proportions of their annual revenue on R&D.